---
document_datetime: 2023-09-21 19:11:06
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/onglyza-epar-all-authorised-presentations_en.pdf
document_name: onglyza-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 1.7427522
conversion_datetime: 2025-12-28 15:07:58.649654
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| EU Number       | (Invented) name   | Strength   | Pharmaceutical Form   | Route of Administration   | Packaging                                 | Package size   |
|-----------------|-------------------|------------|-----------------------|---------------------------|-------------------------------------------|----------------|
| EU/1/09/545/001 | Onglyza           | 5 mg       | Film-coated tablet    | Oral use                  | non-perforated blister (alu/alu)          | 14 tablets     |
| EU/1/09/545/002 | Onglyza           | 5 mg       | Film-coated tablet    | Oral use                  | non-perforated blister (alu/alu)          | 28 tablets     |
| EU/1/09/545/003 | Onglyza           | 5 mg       | Film-coated tablet    | Oral use                  | non-perforated blister (alu/alu)          | 56 tablets     |
| EU/1/09/545/004 | Onglyza           | 5 mg       | Film-coated tablet    | Oral use                  | non-perforated blister (alu/alu)          | 98 tablets     |
| EU/1/09/545/005 | Onglyza           | 5 mg       | Film-coated tablet    | Oral use                  | non-perforated calendar blister (alu/alu) | 14 tablets     |
| EU/1/09/545/006 | Onglyza           | 5 mg       | Film-coated tablet    | Oral use                  | non-perforated calendar blister (alu/alu) | 28 tablets     |
| EU/1/09/545/007 | Onglyza           | 5 mg       | Film-coated tablet    | Oral use                  | non-perforated calendar blister (alu/alu) | 56 tablets     |
| EU/1/09/545/008 | Onglyza           | 5 mg       | Film-coated tablet    | Oral use                  | non-perforated calendar blister (alu/alu) | 98 tablets     |
| EU/1/09/545/009 | Onglyza           | 5 mg       | Film-coated tablet    | Oral use                  | perforated blister (alu/alu)              | 30 x 1 tablets |
| EU/1/09/545/010 | Onglyza           | 5 mg       | Film-coated tablet    | Oral use                  | perforated blister (alu/alu)              | 90 x 1 tablets |
| EU/1/09/545/011 | Onglyza           | 2.5 mg     | Film-coated tablet    | Oral use                  | non-perforated calendar blister (alu/alu) | 14 tablets     |
| EU/1/09/545/012 | Onglyza           | 2.5 mg     | Film-coated tablet    | Oral use                  | non-perforated calendar blister (alu/alu) | 28 tablets     |
| EU/1/09/545/013 | Onglyza           | 2.5 mg     | Film-coated tablet    | Oral use                  | non-perforated calendar blister (alu/alu) | 98 tablets     |
| EU/1/09/545/014 | Onglyza           | 2.5 mg     | Film-coated tablet    | Oral use                  | perforated unit-dose blister (alu/alu)    | 30 x 1 tablets |
| EU/1/09/545/015 | Onglyza           | 2.5 mg     | Film-coated tablet    | Oral use                  | perforated unit-dose blister (alu/alu)    | 90 x 1 tablets |